Articles on Real Life Research

The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control.
Clatworthy J, Price D, Ryan D, Haughney J, Horne R.
Prim Care Respir J. 2009 Dec;18(4):300-5. doi: 10.4104/pcrj.2009.00037.

Inhaler competence in asthma: common errors, barriers to use and recommended solutions.
Inhaler Error Steering Committee, Price D, Bosnic-Anticevich S, Briggs A, Chrystyn H, Rand C, Scheuch G, Bousquet J.
Respir Med. 2013 Jan;107(1):37-46. doi: 10.1016/j.rmed.2012.09.017.

Exploring the role of quantitative feedback in inhaler technique education: a cluster-randomised, two-arm, parallel-group, repeated-measures study.
Toumas-Shehata M, Price D, Basheti IA, Bosnic-Anticevich S.
NPJ Prim Care Respir Med. 2014 Nov 13;24:14071. doi: 10.1038/npjpcrm.2014.71.

Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey
David Price, Monica Fletcher & Thys van der Molen
npj Primary Care Respiratory Medicine 24, Article number: 14009 (2014) doi:10.1038/npjpcrm.2014.9

Time for a new language for asthma control: results from REALISE Asia
Price D, David-Wang A, Cho SH, Ho JCM, Jeong JW, Liam CK, Lin JT, Muttalif AR, Perng DW, Tan TL, Yunus F, Neira G
Journal of Asthma and Allergy Volume 2015:8 Pages 93—103 DOI: 10.2147/JAA.S82633

Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians
David Price, Brooke Harrow, Mark Small, James Pike and Victoria Higgins
World Allergy Organization Journal20158:26 DOI: 10.1186/s40413-015-0075-y

Insights, attitudes, and perceptions about asthma and its treatment: a multinational survey of patients from Europe and Canada
Joaquin Sastre, Leonardo M. Fabbri, David PriceEmail author, Hans Ulrich Wahn, Jean Bousquet, James E. Fish, Kevin Murphy and Malcolm R. Sears
World Allergy Organization Journal 20169:13 DOI: 10.1186/s40413-016-0105-4

Asthma in Asia: Physician perspectives on control, inhaler use and patient communications.
Price D, David-Wang A, Cho SH, Ho JC, Jeong JW, Liam CK, Lin J, Muttalif AR, Perng DW, Tan TL, Yunus F, Neira G.
J Asthma. 2016 May 17:1-9.

Requirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA).
Bousquet J, Van Cauwenberge P, Bachert C, Canonica GW, Demoly P, Durham SR, Fokkens W, Lockey R, Meltzer EO, Mullol J, Naclerio RM, Price D, Simons FE, Vignola AM, Warner JO; European Academy of Allergy and Clinical Immunology (EAACI); Allergic Rhinitis and its Impact on Asthma (ARIA).
Allergy. 2003 Mar;58(3):192-7.

ARIA in the pharmacy: management of allergic rhinitis symptoms in the pharmacy. Allergic rhinitis and its impact on asthma.
Bousquet, P. van Cauwenberge, N. Khaltaev, Members of the workshops: Christine Bond, Sergio Bonini, Helene Bousquet, Jean Bousquet, G. Walter Canonica, Peter Howarth, Nikolai Khaltaev, Marek L Kowalski, Jean-Marc Leder, Richard F. Lockey, Eli O. Meltzer, Robert Naclerio, Kristof Nekam, Maria Pia Orru, David Price, F. Estelle R. Simons, Mary Teresi, Erkka Valovirta, Paul van Cauwenberge, A. Maurizio Vignola, Dennis Williams, Alan Wright
Allergy. 2004 Apr;59(4):373-87.

Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial.
Price DB, Swern A, Tozzi CA, Philip G, Polos P.
Allergy. 2006 Jun;61(6):737-42.

Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN).
Bousquet J, van Cauwenberge P, Aït Khaled N, Bachert C, Baena-Cagnani CE, Bouchard J, Bunnag C, Canonica GW, Carlsen KH, Chen YZ, Cruz AA, Custovic A, Demoly P, Dubakiene R, Durham S, Fokkens W, Howarth P, Kemp J, Kowalski ML, Kvedariene V, Lipworth B, Lockey R, Lund V, Mavale-Manuel S, Meltzer EO, Mullol J, Naclerio R, Nekam K, Ohta K, Papadopoulos N, Passalacqua G, Pawankar R, Popov T, Potter P, Price D, Scadding G, Simons FE, Spicak V, Valovirta E, Wang DY, Yawn B, Yusuf O; GA2LEN.
Allergy. 2006 Sep;61(9):1086-96.

Asthma and allergic rhinitis: Linked in treatment and outcomes
David Price
Ann Thorac Med. 2010 Apr-Jun; 5(2): 63–64. doi:  10.4103/1817-1737.62467

Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper.
Bousquet J, Schünemann HJ, Zuberbier T, Bachert C, Baena-Cagnani CE, Bousquet PJ, Brozek J, Canonica GW, Casale TB, Demoly P, Gerth van Wijk R, Ohta K, Bateman ED, Calderon M, Cruz AA, Dolen WK, Haughney J, Lockey RF, Lötvall J, O’Byrne P, Spranger O, Togias A, Bonini S, Boulet LP, Camargos P, Carlsen KH, Chavannes NH, Delgado L, Durham SR, Fokkens WJ, Fonseca J, Haahtela T, Kalayci O, Kowalski ML, Larenas-Linnemann D, Li J, Mohammad Y, Mullol J, Naclerio R, O’Hehir RE, Papadopoulos N, Passalacqua G, Rabe KF, Pawankar R, Ryan D, Samolinski B, Simons FE, Valovirta E, Yorgancioglu A, Yusuf OM, Agache I, Aït-Khaled N, Annesi-Maesano I, Beghe B, Ben Kheder A, Blaiss MS, Boakye DA, Bouchard J, Burney PG, Busse WW, Chan-Yeung M, Chen Y, Chuchalin AG, Costa DJ, Custovic A, Dahl R, Denburg J, Douagui H, Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Kaliner MA, Keith PK, Kim YY, Klossek JM, Kuna P, Le LT, Lemiere C, Lipworth B, Mahboub B, Malo JL, Marshall GD, Mavale-Manuel S, Meltzer EO, Morais-Almeida M, Motala C, Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka E, Okamoto Y, Orru MP, Ouedraogo S, Palkonen S, Popov TA, Price D, Rosado-Pinto J, Scadding GK, Sooronbaev TM, Stoloff SW, Toskala E, van Cauwenberge P, Vandenplas O, van Weel C, Viegi G, Virchow JC, Wang DY, Wickman M, Williams D, Yawn BP, Zar HJ, Zernotti M, Zhong N; WHO Collaborating Center of Asthma and Rhinitis (Montpellier).
Allergy. 2010 Oct;65(10):1212-21. doi: 10.1111/j.1398-9995.2010.02480.x.

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision.
Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, van Wijk RG, Ohta K, Zuberbier T, Schünemann HJ; Global Allergy and Asthma European Network; Grading of Recommendations Assessment, Development and Evaluation Working Group.
J Allergy Clin Immunol. 2010 Sep;126(3):466-76. doi: 10.1016/j.jaci.2010.06.047.

Severe Chronic Allergic (and Related) Diseases: A Uniform Approach – A MeDALL – GA2LEN – ARIA Position Paper
In collaboration with the WHO Collaborating Center for Asthma and Rhinitis
Lead Author: J Bousquet
Int Arch Allergy Immunol 2012;158:216–231 (DOI:10.1159/000332924)

A new therapy (MP29-02) is effective for the long-term treatment of chronic rhinitis.
Price D, Shah S, Bhatia S, Bachert C, Berger W, Bousquet J, Carr W, Hellings P, Munzel U, Scadding G, Lieberman P.
J Investig Allergol Clin Immunol. 2013;23(7):495-503.

Inhaler competence in asthma: common errors, barriers to use and recommended solutions.
Inhaler Error Steering Committee, Price D, Bosnic-Anticevich S, Briggs A, Chrystyn H, Rand C, Scheuch G, Bousquet J.
Respir Med. 2013 Jan;107(1):37-46. doi: 10.1016/j.rmed.2012.09.017.

A new therapy (MP29-02) is effective for the long-term treatment of chronic rhinitis.
Price D, Shah S, Bhatia S, Bachert C, Berger W, Bousquet J, Carr W, Hellings P, Munzel U, Scadding G, Lieberman P.
J Investig Allergol Clin Immunol. 2013;23(7):495-503.

Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma
David Price, Mike Thomas, John Haughney, Richard A. Lewis, Anne Burden, Julie von Ziegenweidt, Alison Chisholm, Elizabeth V. Hillyer, Christopher J. Corrigan
Respiratory Medicine. July 2013 Volume 107, Issue 7, Pages 987–1000
DOI: http://dx.doi.org/10.1016/j.rmed.2013.03.009

Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone.
Colice G, Martin RJ, Israel E, Roche N, Barnes N, Burden A, Polos P, Dorinsky P, Hillyer EV, Lee AJ, Chisholm A, von Ziegenweidt J, Barion F, Price D.
J Allergy Clin Immunol. 2013 Jul;132(1):45-54. doi: 10.1016/j.jaci.2013.02.008. Epub 2013 Apr 13.

Study on drug costs associated with COPD prescription medicine in Denmark.
Jakobsen M, Anker N, Dollerup J, Poulsen PB, Lange P.
Clin Respir J. 2013 Oct;7(4):328-37. doi: 10.1111/crj.12010. Epub 2013 Jan 22.

Effect of Inhaled Corticosteroid Therapy Step-Down and Dosing Regimen on Measures of Asthma Control
David Price, Alison Chisholm, Elizabeth V Hillyer, Annie Burden, Julie von Ziegenweidt, Henrik Svedsater  and Peter Dale
J Aller Ther 2013, 4:1 DOI: http://dx.doi.org/10.4172/2155-6121.1000126

Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort
Rupert C M Jones, MD, Prof David Price, MD, Dermot Ryan, MD, Erika J Sims, PhD, Julie von Ziegenweidt, Laurence Mascarenhas, MSc, Anne Burden, MSc, David M G Halpin, DPhil, Robert Winter, MD, Prof Sue Hill, PhD, Matt Kearney, MRCGP, Kevin Holton, Anne Moger, MSc, Daryl Freeman, MRCGP, Alison Chisholm, MSc, Prof Eric D Bateman, PhD, on behalf of The Respiratory Effectiveness Group
The Lancet Respiratory Medicine. Volume 2, No. 4, p267–276, April 2014
Published Online: 12 February 2014  DOI: http://dx.doi.org/10.1016/S2213-2600(14)70008-6

The Global Asthma Report 2014

The significance of inhaler technique and how to improve it
David Price
OndrugDelivery 2014

Efficacy of fluticasone propionate/formoterol fumarate in the treatment of asthma: a pooled analysis.
Papi A, Price D, Sastre J, Kaiser K, Lomax M, McIver T, Dissanayake S.
Respir Med. 2015 Feb;109(2):208-17. doi: 10.1016/j.rmed.2014.10.019.

Exploring the role of quantitative feedback in inhaler technique education: a cluster-randomised, two-arm, parallel-group, repeated-measures study.
Toumas-Shehata M, Price D, Basheti IA, Bosnic-Anticevich S.
NPJ Prim Care Respir Med. 2014 Nov 13;24:14071. doi: 10.1038/npjpcrm.2014.71.

Cost-effectiveness of the LABA/LAMA dual bronchodilator indacaterol/glycopyrronium in a Swedish healthcare setting.
Price D, Keininger D, Costa-Scharplatz M, Mezzi K, Dimova M, Asukai Y, Ställberg B.
Respir Med. 2014 Dec;108(12):1786-93. doi: 10.1016/j.rmed.2014.09.015.

Integrated care pathways for airway diseases (AIRWAYS-ICPs).
European Innovation Partnership on Active and Healthy Ageing, Action Plan B3; Mechanisms of the Development of Allergy, WP 10; Global Alliance against Chronic Respiratory Diseases, Bousquet J, Addis A, Adcock I, Agache I, Agusti A, Alonso A, Annesi-Maesano I, Anto JM, Bachert C, Baena-Cagnani CE, Bai C, Baigenzhin A, Barbara C, Barnes PJ, Bateman ED, Beck L, Bedbrook A, Bel EH, Benezet O, Bennoor KS, Benson M, Bernabeu-Wittel M, Bewick M, Bindslev-Jensen C, Blain H, Blasi F, Bonini M, Bonini S, Boulet LP, Bourdin A, Bourret R, Bousquet PJ, Brightling CE, Briggs A, Brozek J, Buhl R, Bush A, Caimmi D, Calderon M, Calverley P, Camargos PA, Camuzat T, Canonica GW, Carlsen KH, Casale TB, Cazzola M, Cepeda Sarabia AM, Cesario A, Chen YZ, Chkhartishvili E, Chavannes NH, Chiron R, Chuchalin A, Chung KF, Cox L, Crooks G, Crooks MG, Cruz AA, Custovic A, Dahl R, Dahlen SE, De Blay F, Dedeu T, Deleanu D, Demoly P, Devillier P, Didier A, Dinh-Xuan AT, Djukanovic R, Dokic D, Douagui H, Dubakiene R, Eglin S, Elliot F, Emuzyte R, Fabbri L, Fink Wagner A, Fletcher M, Fokkens WJ, Fonseca J, Franco A, Frith P, Furber A, Gaga M, Garcés J, Garcia-Aymerich J, Gamkrelidze A, Gonzales-Diaz S, Gouzi F, Guzmán MA, Haahtela T, Harrison D, Hayot M, Heaney LG, Heinrich J, Hellings PW, Hooper J, Humbert M, Hyland M, Iaccarino G, Jakovenko D, Jardim JR, Jeandel C, Jenkins C, Johnston SL, Jonquet O, Joos G, Jung KS, Kalayci O, Karunanithi S, Keil T, Khaltaev N, Kolek V, Kowalski ML, Kull I, Kuna P, Kvedariene V, Le LT, Lodrup Carlsen KC, Louis R, MacNee W, Mair A, Majer I, Manning P, de Manuel Keenoy E, Masjedi MR, Melen E, Melo-Gomes E, Menzies-Gow A, Mercier G, Mercier J, Michel JP, Miculinic N, Mihaltan F, Milenkovic B, Molimard M, Momas I, Montilla-Santana A, Morais-Almeida M, Morgan M, N’Diaye M, Nafti S, Nekam K, Neou A, Nicod L, O’Hehir R, Ohta K, Paggiaro P, Palkonen S, Palmer S, Papadopoulos NG, Papi A, Passalacqua G, Pavord I, Pigearias B, Plavec D, Postma DS, Price D, Rabe KF, Radier Pontal F, Redon J, Rennard S, Roberts J, Robine JM, Roca J, Roche N, Rodenas F, Roggeri A, Rolland C, Rosado-Pinto J, Ryan D, Samolinski B, Sanchez-Borges M, Schünemann HJ, Sheikh A, Shields M, Siafakas N, Sibille Y, Similowski T, Small I, Sola-Morales O, Sooronbaev T, Stelmach R, Sterk PJ, Stiris T, Sud P, Tellier V, To T, Todo-Bom A, Triggiani M, Valenta R, Valero AL, Valiulis A, Valovirta E, Van Ganse E, Vandenplas O, Vasankari T, Vestbo J, Vezzani G, Viegi G, Visier L, Vogelmeier C, Vontetsianos T, Wagstaff R, Wahn U, Wallaert B, Whalley B, Wickman M, Williams DM, Wilson N, Yawn BP, Yiallouros PK, Yorgancioglu A, Yusuf OM, Zar HJ, Zhong N, Zidarn M, Zuberbier T.
Eur Respir J. 2014 Aug;44(2):304-23. doi: 10.1183/09031936.00014614. Epub 2014 Jun 12.

Physician-prescribed Asthma Treatment Regimen does not differ Between Smoking and Non-smoking Patients With Asthma in Seoul and Gyunggi province of Korea
Hae-Sim Park, Ki-Suck Jung, Kian Fan Chung, Felicia Allen-Ramey, Ryan Pollard, Richard Perry, and David Price
Allergy Asthma Immunol Res. 2015 Jan; 7(1): 30–36. Published online 2014 Jul 16. doi:  10.4168/aair.2015.7.1.30

Interstitial lung disease: raising the index of suspicion in primary care.
Zibrak JD, Price D.
NPJ Prim Care Respir Med. 2014 Sep 11;24:14054. doi: 10.1038/npjpcrm.2014.54.

Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial
Chinedu Nwokoro, MBBChir, Hitesh Pandya, MD, Stephen Turner, MD, Prof Sandra Eldridge, PhD, Prof Christopher J Griffiths, MD, Tom Vulliamy, PhD, Prof David Price, MRCGP, Marek Sanak, PhD, John W Holloway, PhD, Rossa Brugha, BMBCh, Lee Koh, BSC, Iain Dickson, MRes, Clare Rutterford, MSc, Prof Jonathan Grigg, MD
Lancet Respiratory Medicine Volume 2, No. 10, p796–803, October 2014 http://dx.doi.org/10.1016/S2213-2600(14)70186-9

Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma? 
David Price, Leonard Fromer, Alan Kaplan, Thys van der Molen & Miguel Román-Rodríguez
npj Primary Care Respiratory Medicine 10.1038/npjpcrm.2014.23 http://dx.doi.org/10.1038/npjpcrm.2014.23

Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification. 
Price DB, Baker CL, Zou KH, Higgins VS, Bailey JT, Pike JS.
Int J Chron Obstruct Pulmon Dis. 2014 May 28;9:551-61. doi: 10.2147/COPD.S62104. eCollection 2014.

Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey
David Price, Monica Fletcher & Thys van der Molen
npj Primary Care Respiratory Medicine 24, Article number: 14009 (2014) doi:10.1038/npjpcrm.2014.9

Current evidence and future research needs for FeNO measurement in respiratory diseases. 
Bjermer L, Alving K, Diamant Z, Magnussen H, Pavord I, Piacentini G, Price D, Roche N, Sastre J, Thomas M, Usmani O.
Respir Med. 2014 Jun;108(6):830-41. doi: 10.1016/j.rmed.2014.02.005. Epub 2014 Feb 15.

Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies. 
Bousquet J, Jorgensen C, Dauzat M, Cesario A, Camuzat T, Bourret R, Best N, Anto JM, Abecassis F, Aubas P, Avignon A, Badin M, Bedbrook A, Blain H, Bourdin A, Bringer J, Camu W, Cayla G, Costa DJ, Courtet P, Cristol JP, Demoly P, de la Coussaye JE, Fesler P, Gouzi F, Gris JC, Guillot B, Hayot M, Jeandel C, Jonquet O, Journot L, Lehmann S, Mathieu G, Morel J, Ninot G, Pelissier J, Picot MC, Radier-Pontal F, Robine JM, Rodier M, Roubille F, Sultan A, Wojtusciszyn A, Auffray C, Balling R, Barbara C, Cambon-Thomsen A, Chavannes NH, Chuchalin A, Crooks G, Dedeu A, Fabbri LM, Garcia-Aymerich J, Hajjam J, Melo Gomes E, Palkonen S, Piette F, Pison C, Price D, Samolinski B, Schunemann HJ, Sterk PJ, Yiallouros P, Roca J, Van de Perre P, Mercier J. 
Curr Pharm Des. 2014;20(38):5928-44.

Detection of airflow limitation using a handheld spirometer in a primary care setting. 
Ching SM, Pang YK, Price D, Cheong AT, Lee PY, Irmi I, Faezah H, Ruhaini I, Chia YC. 
Respirology. 2014 Jul;19(5):689-93. doi: 10.1111/resp.12291. Epub 2014 Apr 7.

Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD
Dirkje S Postma, Nicolas Roche, Gene Colice, Elliot Israel, Richard J Martin, Willem MC van Aalderen, Jonathan Grigg, Anne Burden, Elizabeth V Hillyer, Julie von Ziegenweidt, Gokul Go-palan, and David Price
Int J Chron Obstruct Pulmon Dis. 2014; 9: 1163–1186.
Published online 2014 Oct 17. doi:  10.2147/COPD.S68289

Safety evaluation of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) for allergic rhinitis.
Klimek L, Bousquet J, Price D.
Expert Opin Drug Saf. 2016 Jan;15(1):117-29. doi: 10.1517/14740338.2016.1122755.

The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey
David Price, Glenis Scadding, Dermot Ryan, Claus Bachert, G. Walter Canonica, Joaquim Mullol, Ludger Klimek, Richard Pitman, Sarah Acaster, Ruth Murray and Jean Bousquet
Clinical and Translational Allergy20155:39  DOI: 10.1186/s13601-015-0083-6

A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress.
Hellings PW, Muraro A, Fokkens W, Mullol J, Bachert C, Canonica GW, Price D, Papadopoulos N, Scadding G, Rasp G, Demoly P, Murray R, Bousquet J.
Clin Transl Allergy. 2015 Oct 27;5:36. doi: 10.1186/s13601-015-0080-9.

Dymista®: Eine Klasse für sich* in der Behandlung der allergischen Rhinitis BACK
Dymista®: in a class of its own for the treatment of allergic rhinitis

Jean Bousquet, David Price, Massimo Triggiani, Ludger Klimek
Key Opinions in Medicine

Taking Aim at Asthma Around the World: Global Results of the Asthma Insight and Management Survey in the Asia-Pacific Region, Latin America, Europe, Canada, and the United States.
Nathan RA, Thompson PJ, Price D, Fabbri LM, Salvi S, González-Díaz S, Maspero JF, Moreno-Cantu JJ, Fish JE, Murphy K.
J Allergy Clin Immunol Pract. 2015 Sep-Oct;3(5):734-42.e5. doi: 10.1016/j.jaip.2015.04.013.

MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation.
Bousquet J, Schunemann HJ, Fonseca J, Samolinski B, Bachert C, Canonica GW, Casale T, Cruz AA, Demoly P, Hellings P, Valiulis A, Wickman M, Zuberbier T, Bosnic-Anticevitch S, Bedbrook A, Bergmann KC, Caimmi D, Dahl R, Fokkens WJ, Grisle I, Lodrup Carlsen K, Mullol J, Muraro A, Palkonen S, Papadopoulos N, Passalacqua G, Ryan D, Valovirta E, Yorgancioglu A, Aberer W, Agache I, Adachi M, Akdis CA, Akdis M, Annesi-Maesano I, Ansotegui IJ, Anto JM, Arnavielhe S, Arshad H, Baiardini I, Baigenzhin AK, Barbara C, Bateman ED, Beghé B, Bel EH, Ben Kheder A, Bennoor KS, Benson M, Bewick M, Bieber T, Bindslev-Jensen C, Bjermer L, Blain H, Boner AL, Boulet LP, Bonini M, Bonini S, Bosse I, Bourret R, Bousquet PJ, Braido F, Briggs AH, Brightling CE, Brozek J, Buhl R, Burney PG, Bush A, Caballero-Fonseca F, Calderon MA, Camargos PA, Camuzat T, Carlsen KH, Carr W, Cepeda Sarabia AM, Chavannes NH, Chatzi L, Chen YZ, Chiron R, Chkhartishvili E, Chuchalin AG, Ciprandi G, Cirule I, Correia de Sousa J, Cox L, Crooks G, Costa DJ, Custovic A, Dahlen SE, Darsow U, De Carlo G, De Blay F, Dedeu T, Deleanu D, Denburg JA, Devillier P, Didier A, Dinh-Xuan AT, Dokic D, Douagui H, Dray G, Dubakiene R, Durham SR, Dykewicz MS, El-Gamal Y, Emuzyte R, Fink Wagner A, Fletcher M, Fiocchi A, Forastiere F, Gamkrelidze A, Gemicioğlu B, Gereda JE, González Diaz S, Gotua M, Grouse L, Guzmán MA, Haahtela T, Hellquist-Dahl B, Heinrich J, Horak F, Hourihane JO, Howarth P, Humbert M, Hyland ME, Ivancevich JC, Jares EJ, Johnston SL, Joos G, Jonquet O, Jung KS, Just J, Kaidashev I, Kalayci O, Kalyoncu AF, Keil T, Keith PK, Khaltaev N, Klimek L, Koffi N’Goran B, Kolek V, Koppelman GH, Kowalski ML, Kull I, Kuna P, Kvedariene V, Lambrecht B, Lau S, Larenas-Linnemann D, Laune D, Le LT, Lieberman P, Lipworth B, Li J, Louis R, Magard Y, Magnan A, Mahboub B, Majer I, Makela MJ, Manning P, De Manuel Keenoy E, Marshall GD, Masjedi MR, Maurer M, Mavale-Manuel S, Melén E, Melo-Gomes E, Meltzer EO, Merk H, Miculinic N, Mihaltan F, Milenkovic B, Mohammad Y, Molimard M, Momas I, Montilla-Santana A, Morais-Almeida M, Mösges R, Namazova-Baranova L, Naclerio R, Neou A, Neffen H, Nekam K, Niggemann B, Nyembue TD, O’Hehir RE, Ohta K, Okamoto Y, Okubo K, Ouedraogo S, Paggiaro P, Pali-Schöll I, Palmer S, Panzner P, Papi A, Park HS, Pavord I, Pawankar R, Pfaar O, Picard R, Pigearias B, Pin I, Plavec D, Pohl W, Popov TA, Portejoie F, Postma D, Potter P, Price D, Rabe KF, Raciborski F, Radier Pontal F, Repka-Ramirez S, Robalo-Cordeiro C, Rolland C, Rosado-Pinto J, Reitamo S, Rodenas F, Roman Rodriguez M, Romano A, Rosario N, Rosenwasser L, Rottem M, Sanchez-Borges M, Scadding GK, Serrano E, Schmid-Grendelmeier P, Sheikh A, Simons FE, Sisul JC, Skrindo I, Smit HA, Solé D, Sooronbaev T, Spranger O, Stelmach R, Strandberg T, Sunyer J, Thijs C, Todo-Bom A, Triggiani M, Valenta R, Valero AL, van Hage M, Vandenplas O, Vezzani G, Vichyanond P, Viegi G, Wagenmann M, Walker S, Wang DY, Wahn U, Williams DM, Wright J, Yawn BP, Yiallouros PK, Yusuf OM, Zar HJ, Zernotti ME, Zhang L, Zhong N, Zidarn M, Mercier J.
Allergy. 2015 Nov;70(11):1372-92. doi: 10.1111/all.12686.

Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps.
Bousquet J, Bachert C, Bernstein J, Canonica GW, Carr W, Dahl R, Demoly P, Devillier P, Hellings P, Fokkens W, Klimek L, Lieberman P, Meltzer E, Price D, Ryan D, Wahn U.
Expert Opin Pharmacother. 2015 Apr;16(6):913-28. doi: 10.1517/14656566.2015.1020789.

Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: results from a noninterventional study.
Klimek L, Bachert C, Mösges R, Munzel U, Price D, Virchow JC, Wahn U, Bousquet J.
Allergy Asthma Proc. 2015 Jan-Feb;36(1):40-7. doi: 10.2500/aap.2015.36.3823.

MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis.
Bousquet J, Schünemann HJ, Hellings PW, Arnavielhe S, Bachert C, Bedbrook A, Bergmann KC, Bosnic-Anticevich S, Brozek J, Calderon M, Canonica GW, Casale TB, Chavannes NH, Cox L, Chrystyn H, Cruz AA, Dahl R, De Carlo G, Demoly P, Devillier P, Dray G, Fletcher M, Fokkens WJ, Fonseca J, Gonzalez-Diaz SN, Grouse L, Keil T, Kuna P, Larenas-Linnemann D, Lodrup Carlsen KC, Meltzer EO, Mullol J, Muraro A, Naclerio RN, Palkonen S, Papadopoulos NG, Passalacqua G, Price D, Ryan D, Samolinski B, Scadding GK, Sheikh A, Valiulis A, Valovirta E, Walker S, Wickman M, Yorgancioglu A, Zuberbier T; MASK study group.
J Allergy Clin Immunol. 2016 Apr 23. pii: S0091-6749(16)30148-8. doi: 10.1016/j.jaci.2016.03.025.

Effectiveness of allergic rhinitis treatments in real-life with a focus on MP-AzeFlu.
Klimek L, Demoly P, Price D.
Expert Rev Clin Pharmacol. 2016 May;9(5):705-14. doi: 10.1586/17512433.2016.1148598.

Safety evaluation of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) for allergic rhinitis.
Klimek L, Bousquet J, Price D.
Expert Opin Drug Saf. 2016 Jan;15(1):117-29. doi: 10.1517/14740338.2016.1122755.

Current evidence and future research needs for FeNO measurement in respiratory diseases. 
Bjermer L, Alving K, Diamant Z, Magnussen H, Pavord I, Piacentini G, Price D, Roche N, Sastre J, Thomas M, Usmani O.
Respir Med. 2014 Jun;108(6):830-41. doi: 10.1016/j.rmed.2014.02.005. Epub 2014 Feb 15.

Blood and sputum biomarkers in COPD and asthma: a review
Paone, V. Leone, V. Conti, L. De Marchis, E. Ialleni, C. Graziani, M. Salducci, M. Ramaccia, G. Munafò
Eur Rev Med Pharmacol Sci 2016; 20 (4): 698-708

Inhaled corticosteroid dose-response on blood eosinophils in asthma
Brian Lipworth, Sunny Jabbal, Arvind Manoharan, William Anderson, Philip Short
The Lancet Respiratory Medicine Volume 4, No. 1, e1, January 2016 DOI: 10.1016/S2213-2600(15)00504-4

Biomarkers in asthmatic patients: Has their time come to direct treatment?
Berry A, Busse WW.
J Allergy Clin Immunol. 2016 May;137(5):1317-24.

Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial
Chinedu Nwokoro, MBBChir, Hitesh Pandya, MD, Stephen Turner, MD, Prof Sandra Eldridge, PhD, Prof Christopher J Griffiths, MD, Tom Vulliamy, PhD, Prof David Price, MRCGP, Marek Sanak, PhD, John W Holloway, PhD, Rossa Brugha, BMBCh, Lee Koh, BSC, Iain Dickson, MRes, Clare Rutterford, MSc, Prof Jonathan Grigg, MD
Lancet Respiratory Medicine Volume 2, No. 10, p796–803, October 2014 http://dx.doi.org/10.1016/S2213-2600(14)70186-9

Monitoring asthma in childhood: symptoms, exacerbations and quality of life.
Brand PL, Mäkelä MJ, Szefler SJ, Frischer T, Price D; ERS Task Force Monitoring Asthma in Children.
Eur Respir Rev. 2015 Jun;24(136):187-93. doi: 10.1183/16000617.00003614.

Monitoring asthma in children
Mariëlle W. Pijnenburg, Eugenio Baraldi, Paul L.P. Brand, Kai-Håkon Carlsen, Ernst Eber, Thomas Frischer, Gunilla Hedlin, Neeta Kulkarni, Christiane Lex, Mika J. Mäkelä, Eva Mantzouranis, Alexander Moeller, Ian Pavord, Giorgio Piacentini, David Price, Bart L. Rottier, Sejal Saglani, Peter D. Sly, Stanley J. Szefler, Thomy Tonia, Steve Turner, Edwina Wooler, Karin C. Lødrup Carlsen
European Respiratory Journal Vol 48 Issue 1 DOI: 10.1183/09031936.00088814 Published 5 March 2015

How to match the optimal currently available inhaler device to an individual child with asthma or recurrent wheeze.
van Aalderen WM, Garcia-Marcos L, Gappa M, Lenney W, Pedersen S, Dekhuijzen R, Price D.
NPJ Prim Care Respir Med. 2015 Jan 8;25:14088. doi: 10.1038/npjpcrm.2014.88.

Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial
Chinedu Nwokoro, MBBChir, Hitesh Pandya, MD, Stephen Turner, MD, Prof Sandra Eldridge, PhD, Prof Christopher J Griffiths, MD, Tom Vulliamy, PhD, Prof David Price, MRCGP, Marek Sanak, PhD, John W Holloway, PhD, Rossa Brugha, BMBCh, Lee Koh, BSC, Iain Dickson, MRes, Clare Rutterford, MSc, Prof Jonathan Grigg, MD
Lancet Respiratory Medicine Volume 2, No. 10, p796–803, October 2014 http://dx.doi.org/10.1016/S2213-2600(14)70186-9

Clinically important improvements in asthma-specific quality of life, but no difference in conventional clinical indexes in patients changed from conventional beclomethasone dipropionate to approximately half the dose of extrafine beclomethasone dipropionate.
Juniper EF, Price DB, Stampone PA, Creemers JP, Mol SJ, Fireman P.
Chest. 2002 Jun;121(6):1824-32.

Adjustable and fixed dosing with budesonide/ formoterol via a single inhaler in asthma patients: the ASSURE study.
Ind PW, Haughney J, Price D, Rosen JP, Kennelly J.
Respir Med. 2004 May;98(5):464-75.

Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: a real-world observational study.
Price D, Martin RJ, Barnes N, Dorinsky P, Israel E, Roche N, Chisholm A, Hillyer EV, Kemp L, Lee AJ, von Ziegenweidt J, Colice G.
J Allergy Clin Immunol. 2010 Sep;126(3):511-8.e1-10. doi: 10.1016/j.jaci.2010.06.040. Epub 2010 Aug 9.

Observational study comparing intranasal mometasone furoate with oral antihistamines for rhinitis and asthma.
Price D, Kemp L, Sims E, von Ziegenweidt J, Navaratnam P, Lee AJ, Chisholm A, Hillyer EV, Gopalan G.
Prim Care Respir J. 2010 Sep;19(3):266-73. doi: 10.4104/pcrj.2010.00040.

Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD.
Price D, Haughney J, Sims E, Ali M, von Ziegenweidt J, Hillyer EV, Lee AJ, Chisholm A, Barnes N.
J Asthma Allergy. 2011;4:37-47. doi: 10.2147/JAA.S17709. Epub 2011 Apr 28.

A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study)
D Price, S Musgrave, E Wilson, E Sims, L Shepstone, A Blyth, J Murdoch, M Mugford, E Juniper, J Ayres, S Wolfe, D Freeman, A Lipp, R Gilbert and I Harvey
Health Technology Assessment 2011; Vol. 15: No. 21 ISSN 1366-5278 May 2011 10.3310/hta15210

Asthma control with extrafine-particle hydrofluoroalkane–beclometasone vs. large-particle chlorofluorocarbon–beclometasone: a real-world observational study
Barnes, D. Price, G. Colice, A. Chisholm, P. Dorinsky, E. V. Hillyer, A. Burden, A. J. Lee, R. J. Martin, N. Roche, J. von Ziegenweidt and E. Israel
Clin Exp Allergy. 2011 Nov;41(11):1521-32. doi: 10.1111/j.1365-2222.2011.03820.x. Epub 2011 Jul 14.

The at-risk registers in severe asthma (ARRISA) study: a cluster-randomised controlled trial examining effectiveness and costs in primary care.
Smith JR, Noble MJ, Musgrave S, Murdoch J, Price GM, Barton GR, Windley J, Holland R, Harrison BD, Howe A, Price DB, Harvey I, Wilson AM.
Thorax. 2012 Dec;67(12):1052-60. doi: 10.1136/thoraxjnl-2012-202093.

Efficacy of fluticasone propionate/formoterol fumarate in the treatment of asthma: a pooled analysis.
Papi A, Price D, Sastre J, Kaiser K, Lomax M, McIver T, Dissanayake S.
Respir Med. 2015 Feb;109(2):208-17. doi: 10.1016/j.rmed.2014.10.019.

Cost-effectiveness of the LABA/LAMA dual bronchodilator indacaterol/glycopyrronium in a Swedish healthcare setting.
Price D, Keininger D, Costa-Scharplatz M, Mezzi K, Dimova M, Asukai Y, Ställberg B.
Respir Med. 2014 Dec;108(12):1786-93. doi: 10.1016/j.rmed.2014.09.015.

Physician-prescribed Asthma Treatment Regimen does not differ Between Smoking and Non-smoking Patients With Asthma in Seoul and Gyunggi province of Korea
Hae-Sim Park, Ki-Suck Jung, Kian Fan Chung, Felicia Allen-Ramey, Ryan Pollard, Richard Perry, and David Price
Allergy Asthma Immunol Res. 2015 Jan; 7(1): 30–36. Published online 2014 Jul 16. doi:  10.4168/aair.2015.7.1.30

Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD
Dirkje S Postma, Nicolas Roche, Gene Colice, Elliot Israel, Richard J Martin, Willem MC van Aalderen, Jonathan Grigg, Anne Burden, Elizabeth V Hillyer, Julie von Ziegenweidt, Gokul Go-palan, and David Price
Int J Chron Obstruct Pulmon Dis. 2014; 9: 1163–1186.
Published online 2014 Oct 17. doi:  10.2147/COPD.S68289

Dual bronchodilator therapy with aclidinium bromide/formoterol fumarate for chronic obstructive pulmonary disease.
D’Urzo T, Donohue JF, Price D, Miravitlles M, Kerwin E.
Expert Rev Respir Med. 2015 Oct;9(5):519-32. doi: 10.1586/17476348.2015.1081065.

Monitoring asthma in childhood: symptoms, exacerbations and quality of life.
Brand PL, Mäkelä MJ, Szefler SJ, Frischer T, Price D; ERS Task Force Monitoring Asthma in Children.
Eur Respir Rev. 2015 Jun;24(136):187-93. doi: 10.1183/16000617.00003614.

Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial.
Devereux G, Cotton S, Barnes P, Briggs A, Burns G, Chaudhuri R, Chrystyn H, Davies L, De Soyza A, Fielding S, Gompertz S, Haughney J, Lee AJ, McCormack K, McPherson G, Morice A, Norrie J17, Sullivan A, Wilson A, Price D.
Trials. 2015 Jun 10;16:267. doi: 10.1186/s13063-015-0782-2.

Cost-Effectiveness of Glycopyrronium Bromide Compared with Tiotropium in Patients with Chronic Obstructive Pulmonary Disease in Sweden.
Costa-Scharplatz M, Ställberg B, Goyal P, Asukai Y, Gruenberger JB, Price D.
Appl Health Econ Health Policy. 2015 Dec;13(6):637-45. doi: 10.1007/s40258-015-0193-2.

Assessing the clinical value of fast onset and sustained duration of action of long-acting bronchodilators for COPD.
Cazzola M, Beeh KM, Price D, Roche N.
Pulm Pharmacol Ther. 2015 Apr;31:68-78. doi: 10.1016/j.pupt.2015.02.007. Epub 2015 Feb 26.[/vc_tta_section][vc_tta_section title=”COPD” tab_id=”1469007772253-c2a760c6-f901″]COPD screening efforts in primary care: what is the yield?
Tinkelman DG1, Price D, Nordyke RJ, Halbert RJ.
Prim Care Respir J. 2007 Feb;16(1):41-8.

Exacerbation rate, health status and mortality in COPD – a review of potential interventions.
Terence AR Seemungal, John R Jurst, Jadwiga A Wedzicha
Int J Chron Obstruct Pulmon Dis. 2009; 4: 203–223.
Published online 2009 Jun 11.

Characteristics of Dutch and Swiss primary care COPD patients – baseline data of the ICE COLD ERIC study.
Siebeling L, Puhan MA, Muggensturm P, Zoller M, Ter Riet G.
Clin Epidemiol. 2011;3:273-83. doi: 10.2147/CLEP.S24818. Epub 2011 Oct 12.

Stakeholder priorities for comparative effectiveness research in chronic obstructive pulmonary disease: a workshop report.
Krishnan JA, Lindenauer PK, Au DH, Carson SS, Lee TA, McBurnie MA, Naureckas ET, Vollmer WM, Mularski RA; COPD Outcomes-based Network for Clinical Effectiveness and Research Translation.
Am J Respir Crit Care Med. 2013 Feb 1;187(3):320-6. doi: 10.1164/rccm.201206-0994WS. Epub 2012 Nov 15.

Impact of night-time symptoms in COPD: a real-world study in five European countries
Price D, Small M, Milligan G, Higgins V, Garcia Gil E, Estruch J
International Journal of Chronic Obstructive Pulmonary Disease Volume 2013:8 Pages 595—603
DOI 10.2147/COPD.S48570

Characteristics of patients preferring once-daily controller therapy for asthma and COPD: a retrospective cohort study
David Price, Amanda J Lee, Erika J Sims, Linda Kemp, Elizabeth V Hillyer, Alison Chisholm, Julie von Ziegenweidt & Angela Williams
Primary Care Respiratory Journal (2013) 22, 161–168
Published online: 04 March 2013.  doi:10.4104/pcrj.2013.00017

Study on drug costs associated with COPD prescription medicine in Denmark.
Jakobsen M, Anker N, Dollerup J, Poulsen PB, Lange P.
Clin Respir J. 2013 Oct;7(4):328-37. doi: 10.1111/crj.12010. Epub 2013 Jan 22.

Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort
Rupert C M Jones, MD, Prof David Price, MD, Dermot Ryan, MD, Erika J Sims, PhD, Julie von Ziegenweidt, Laurence Mascarenhas, MSc, Anne Burden, MSc, David M G Halpin, DPhil, Robert Winter, MD, Prof Sue Hill, PhD, Matt Kearney, MRCGP, Kevin Holton, Anne Moger, MSc, Daryl Freeman, MRCGP, Alison Chisholm, MSc, Prof Eric D Bateman, PhD, on behalf of The Respiratory Effectiveness Group
The Lancet Respiratory Medicine. Volume 2, No. 4, p267–276, April 2014
Published Online: 12 February 2014  DOI: http://dx.doi.org/10.1016/S2213-2600(14)70008-6

Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD
Dirkje S Postma, Nicolas Roche, Gene Colice, Elliot Israel, Richard J Martin, Willem MC van Aalderen, Jonathan Grigg, Anne Burden, Elizabeth V Hillyer, Julie von Ziegenweidt, Gokul Go-palan, and David Price
Int J Chron Obstruct Pulmon Dis. 2014; 9: 1163–1186.
Published online 2014 Oct 17. doi:  10.2147/COPD.S68289

The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK
Brusselle G, Price D, Gruffydd-Jones K, Miravitlles M, Keininger DL, Stewart R, Baldwin M, Jones RC
International Journal of Chronic Obstructive Pulmonary Disease Volume 2015:10(1) Pages 2207—2217 DOI 10.2147/COPD.S91694

Dual bronchodilator therapy with aclidinium bromide/formoterol fumarate for chronic obstructive pulmonary disease.
D’Urzo T, Donohue JF, Price D, Miravitlles M, Kerwin E.
Expert Rev Respir Med. 2015 Oct;9(5):519-32. doi: 10.1586/17476348.2015.1081065.

Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial.
Devereux G, Cotton S, Barnes P, Briggs A, Burns G, Chaudhuri R, Chrystyn H, Davies L, De Soyza A, Fielding S, Gompertz S, Haughney J, Lee AJ, McCormack K, McPherson G, Morice A, Norrie J17, Sullivan A, Wilson A, Price D.
Trials. 2015 Jun 10;16:267. doi: 10.1186/s13063-015-0782-2.

Cost-Effectiveness of Glycopyrronium Bromide Compared with Tiotropium in Patients with Chronic Obstructive Pulmonary Disease in Sweden.
Costa-Scharplatz M, Ställberg B, Goyal P, Asukai Y, Gruenberger JB, Price D.
Appl Health Econ Health Policy. 2015 Dec;13(6):637-45. doi: 10.1007/s40258-015-0193-2.

Controversies in COPD: Screening and Case Finding
Joan B. Soriano and David Price
ERS Monograph. DOI: 10.1183/2312508X.10018914

Assessing the clinical value of fast onset and sustained duration of action of long-acting bronchodilators for COPD.
Cazzola M, Beeh KM, Price D, Roche N.
Pulm Pharmacol Ther. 2015 Apr;31:68-78. doi: 10.1016/j.pupt.2015.02.007. Epub 2015 Feb 26.

Blood and sputum biomarkers in COPD and asthma: a review
Paone, V. Leone, V. Conti, L. De Marchis, E. Ialleni, C. Graziani, M. Salducci, M. Ramaccia, G. Munafò
Eur Rev Med Pharmacol Sci 2016; 20 (4): 698-708

Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.
Jones RC, Price D, Chavannes NH, Lee AJ, Hyland ME, Ställberg B, Lisspers K, Sundh J, van der Molen T, Tsiligianni I; UNLOCK Group of the IPCRG.
NPJ Prim Care Respir Med. 2016 Apr 7;26:16010. doi: 10.1038/npjpcrm.2016.10.

A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease
Anthony D’Urzo, James F Donohue, Peter Kardos, Marc Miravitlles, and David Price.
Expert Opin Pharmacother. 2015 Aug 13; 16(12): 1845–1860. doi:  10.1517/14656566.2015.1067682[/vc_tta_section][vc_tta_section title=”Cost Effectiveness” tab_id=”1469007970716-e8a6be25-ae9e”]The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey
David Price, Glenis Scadding, Dermot Ryan, Claus Bachert, G. Walter Canonica, Joaquim Mullol, Ludger Klimek, Richard Pitman, Sarah Acaster, Ruth Murray and Jean Bousquet
Clinical and Translational Allergy20155:39  DOI: 10.1186/s13601-015-0083-6

Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians
David Price, Brooke Harrow, Mark Small, James Pike and Victoria Higgins
World Allergy Organization Journal20158:26 DOI: 10.1186/s40413-015-0075-y

Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study.
Braido F, Brusselle G, Guastalla D, Ingrassia E, Nicolini G, Price D, Roche N, Soriano JB, Worth H; LIAISON Study Group.
Respir Res. 2016 May 14;17(1):51. doi: 10.1186/s12931-016-0374-z.

The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement.
Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, Sørensen HT, von Elm E, Langan SM; RECORD Working Committee.
PLoS Med. 2015 Oct 6;12(10):e1001885. doi: 10.1371/journal.pmed.1001885.

Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial.
Devereux G, Cotton S, Barnes P, Briggs A, Burns G, Chaudhuri R, Chrystyn H, Davies L, De Soyza A, Fielding S, Gompertz S, Haughney J, Lee AJ, McCormack K, McPherson G, Morice A, Norrie J17, Sullivan A, Wilson A, Price D.
Trials. 2015 Jun 10;16:267. doi: 10.1186/s13063-015-0782-2.

Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians
David Price, Brooke Harrow, Mark Small, James Pike and Victoria Higgins
World Allergy Organization Journal20158:26 DOI: 10.1186/s40413-015-0075-y

Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps.
Bousquet J, Bachert C, Bernstein J, Canonica GW, Carr W, Dahl R, Demoly P, Devillier P, Hellings P, Fokkens W, Klimek L, Lieberman P, Meltzer E, Price D, Ryan D, Wahn U.
Expert Opin Pharmacother. 2015 Apr;16(6):913-28. doi: 10.1517/14656566.2015.1020789.

Asthma in Asia: Physician perspectives on control, inhaler use and patient communications.
Price D, David-Wang A, Cho SH, Ho JC, Jeong JW, Liam CK, Lin J, Muttalif AR, Perng DW, Tan TL, Yunus F, Neira G.
J Asthma. 2016 May 17:1-9.

Safety evaluation of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) for allergic rhinitis.
Klimek L, Bousquet J, Price D.
Expert Opin Drug Saf. 2016 Jan;15(1):117-29. doi: 10.1517/14740338.2016.1122755.

A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease
Anthony D’Urzo, James F Donohue, Peter Kardos, Marc Miravitlles, and David Price.
Expert Opin Pharmacother. 2015 Aug 13; 16(12): 1845–1860. doi:  10.1517/14656566.2015.1067682

The REporting of Studies Conducted Using Observational Routinely-Collected Health Data (RECORD) Statement: Methods for Arriving at Consensus and Developing Reporting Guidelines.
Nicholls SG, Quach P, von Elm E, Guttmann A, Moher D, Petersen I, Sørensen HT, Smeeth L, Langan SM, Benchimol EI.
PLoS One. 2015 May 12;10(5):e0125620. doi: 10.1371/journal.pone.0125620.

MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation.
Bousquet J, Schunemann HJ, Fonseca J, Samolinski B, Bachert C, Canonica GW, Casale T, Cruz AA, Demoly P, Hellings P, Valiulis A, Wickman M, Zuberbier T, Bosnic-Anticevitch S, Bedbrook A, Bergmann KC, Caimmi D, Dahl R, Fokkens WJ, Grisle I, Lodrup Carlsen K, Mullol J, Muraro A, Palkonen S, Papadopoulos N, Passalacqua G, Ryan D, Valovirta E, Yorgancioglu A, Aberer W, Agache I, Adachi M, Akdis CA, Akdis M, Annesi-Maesano I, Ansotegui IJ, Anto JM, Arnavielhe S, Arshad H, Baiardini I, Baigenzhin AK, Barbara C, Bateman ED, Beghé B, Bel EH, Ben Kheder A, Bennoor KS, Benson M, Bewick M, Bieber T, Bindslev-Jensen C, Bjermer L, Blain H, Boner AL, Boulet LP, Bonini M, Bonini S, Bosse I, Bourret R, Bousquet PJ, Braido F, Briggs AH, Brightling CE, Brozek J, Buhl R, Burney PG, Bush A, Caballero-Fonseca F, Calderon MA, Camargos PA, Camuzat T, Carlsen KH, Carr W, Cepeda Sarabia AM, Chavannes NH, Chatzi L, Chen YZ, Chiron R, Chkhartishvili E, Chuchalin AG, Ciprandi G, Cirule I, Correia de Sousa J, Cox L, Crooks G, Costa DJ, Custovic A, Dahlen SE, Darsow U, De Carlo G, De Blay F, Dedeu T, Deleanu D, Denburg JA, Devillier P, Didier A, Dinh-Xuan AT, Dokic D, Douagui H, Dray G, Dubakiene R, Durham SR, Dykewicz MS, El-Gamal Y, Emuzyte R, Fink Wagner A, Fletcher M, Fiocchi A, Forastiere F, Gamkrelidze A, Gemicioğlu B, Gereda JE, González Diaz S, Gotua M, Grouse L, Guzmán MA, Haahtela T, Hellquist-Dahl B, Heinrich J, Horak F, Hourihane JO, Howarth P, Humbert M, Hyland ME, Ivancevich JC, Jares EJ, Johnston SL, Joos G, Jonquet O, Jung KS, Just J, Kaidashev I, Kalayci O, Kalyoncu AF, Keil T, Keith PK, Khaltaev N, Klimek L, Koffi N’Goran B, Kolek V, Koppelman GH, Kowalski ML, Kull I, Kuna P, Kvedariene V, Lambrecht B, Lau S, Larenas-Linnemann D, Laune D, Le LT, Lieberman P, Lipworth B, Li J, Louis R, Magard Y, Magnan A, Mahboub B, Majer I, Makela MJ, Manning P, De Manuel Keenoy E, Marshall GD, Masjedi MR, Maurer M, Mavale-Manuel S, Melén E, Melo-Gomes E, Meltzer EO, Merk H, Miculinic N, Mihaltan F, Milenkovic B, Mohammad Y, Molimard M, Momas I, Montilla-Santana A, Morais-Almeida M, Mösges R, Namazova-Baranova L, Naclerio R, Neou A, Neffen H, Nekam K, Niggemann B, Nyembue TD, O’Hehir RE, Ohta K, Okamoto Y, Okubo K, Ouedraogo S, Paggiaro P, Pali-Schöll I, Palmer S, Panzner P, Papi A, Park HS, Pavord I, Pawankar R, Pfaar O, Picard R, Pigearias B, Pin I, Plavec D, Pohl W, Popov TA, Portejoie F, Postma D, Potter P, Price D, Rabe KF, Raciborski F, Radier Pontal F, Repka-Ramirez S, Robalo-Cordeiro C, Rolland C, Rosado-Pinto J, Reitamo S, Rodenas F, Roman Rodriguez M, Romano A, Rosario N, Rosenwasser L, Rottem M, Sanchez-Borges M, Scadding GK, Serrano E, Schmid-Grendelmeier P, Sheikh A, Simons FE, Sisul JC, Skrindo I, Smit HA, Solé D, Sooronbaev T, Spranger O, Stelmach R, Strandberg T, Sunyer J, Thijs C, Todo-Bom A, Triggiani M, Valenta R, Valero AL, van Hage M, Vandenplas O, Vezzani G, Vichyanond P, Viegi G, Wagenmann M, Walker S, Wang DY, Wahn U, Williams DM, Wright J, Yawn BP, Yiallouros PK, Yusuf OM, Zar HJ, Zernotti ME, Zhang L, Zhong N, Zidarn M, Mercier J.
Allergy. 2015 Nov;70(11):1372-92. doi: 10.1111/all.12686.

MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis.
Bousquet J, Schünemann HJ, Hellings PW, Arnavielhe S, Bachert C, Bedbrook A, Bergmann KC, Bosnic-Anticevich S, Brozek J, Calderon M, Canonica GW, Casale TB, Chavannes NH, Cox L, Chrystyn H, Cruz AA, Dahl R, De Carlo G, Demoly P, Devillier P, Dray G, Fletcher M, Fokkens WJ, Fonseca J, Gonzalez-Diaz SN, Grouse L, Keil T, Kuna P, Larenas-Linnemann D, Lodrup Carlsen KC, Meltzer EO, Mullol J, Muraro A, Naclerio RN, Palkonen S, Papadopoulos NG, Passalacqua G, Price D, Ryan D, Samolinski B, Scadding GK, Sheikh A, Valiulis A, Valovirta E, Walker S, Wickman M, Yorgancioglu A, Zuberbier T; MASK study group.
J Allergy Clin Immunol. 2016 Apr 23. pii: S0091-6749(16)30148-8. doi: 10.1016/j.jaci.2016.03.025.[/vc_tta_section][vc_tta_section title=”Commentary & Calls for Action” tab_id=”1469008891254-6106dc1f-1e88″]Letter from the Editor
David Price
European Respiratory and Pulmonary Diseases, 2015;1(1):13 DOI: 10.17925/ERPD.2015.01.01.13

Controversies in COPD: Screening and Case Finding
Joan B. Soriano and David Price
ERS Monograph. DOI: 10.1183/2312508X.10018914

Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study.
Braido F, Brusselle G, Guastalla D, Ingrassia E, Nicolini G, Price D, Roche N, Soriano JB, Worth H; LIAISON Study Group.
Respir Res. 2016 May 14;17(1):51. doi: 10.1186/s12931-016-0374-z.

The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement.
Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, Sørensen HT, von Elm E, Langan SM; RECORD Working Committee.
PLoS Med. 2015 Oct 6;12(10):e1001885. doi: 10.1371/journal.pmed.1001885.

Assessing the Gold Standard — Lessons from the History of RCTs
Laura E. Bothwell, Ph.D., Jeremy A. Greene, M.D., Ph.D., Scott H. Podolsky, M.D., and David S. Jones, M.D., Ph.D.
N Engl J Med 2016; 374:2175-2181June 2, 2016 DOI: 10.1056/NEJMms1604593

Integrating Randomized Comparative Effectiveness Research with Patient Care
Louis D. Fiore, M.D., M.P.H., and Philip W. Lavori, Ph.D.
N Engl J Med 2016;374:2152-8. DOI: 10.1056/NEJMra1510057[/vc_tta_section][vc_tta_section title=”Interstitial Lung Disease” tab_id=”1469009111530-74532c16-af6e”]Interstitial lung disease: raising the index of suspicion in primary care.
Zibrak JD, Price D.
NPJ Prim Care Respir Med. 2014 Sep 11;24:14054. doi: 10.1038/npjpcrm.2014.54.[/vc_tta_section][vc_tta_section title=”Patient-Centred Care” tab_id=”1469009369028-d01a62fc-1fe3″]Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey
David Price, Monica Fletcher & Thys van der Molen
npj Primary Care Respiratory Medicine 24, Article number: 14009 (2014) doi:10.1038/npjpcrm.2014.9

Time for a new language for asthma control: results from REALISE Asia
Price D, David-Wang A, Cho SH, Ho JCM, Jeong JW, Liam CK, Lin JT, Muttalif AR, Perng DW, Tan TL, Yunus F, Neira G
Journal of Asthma and Allergy Volume 2015:8 Pages 93—103 DOI: 10.2147/JAA.S82633

Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study.
Braido F, Brusselle G, Guastalla D, Ingrassia E, Nicolini G, Price D, Roche N, Soriano JB, Worth H; LIAISON Study Group.
Respir Res. 2016 May 14;17(1):51. doi: 10.1186/s12931-016-0374-z.

Insights, attitudes, and perceptions about asthma and its treatment: a multinational survey of patients from Europe and Canada
Joaquin Sastre, Leonardo M. Fabbri, David PriceEmail author, Hans Ulrich Wahn, Jean Bousquet, James E. Fish, Kevin Murphy and Malcolm R. Sears
World Allergy Organization Journal 20169:13 DOI: 10.1186/s40413-016-0105-4

Asthma-specific health-related quality of life of people in Great Britain: A national survey.
Upton J, Lewis C, Humphreys E, Price D, Walker S.
J Asthma. 2016 Apr 26:1-8.

Asthma in Asia: Physician perspectives on control, inhaler use and patient communications.
Price D, David-Wang A, Cho SH, Ho JC, Jeong JW, Liam CK, Lin J, Muttalif AR, Perng DW, Tan TL, Yunus F, Neira G.
J Asthma. 2016 May 17:1-9.[/vc_tta_section][vc_tta_section title=”Prescribing Practice” tab_id=”1469009507039-3b0a208b-9bd1″]The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK
Brusselle G, Price D, Gruffydd-Jones K, Miravitlles M, Keininger DL, Stewart R, Baldwin M, Jones RC
International Journal of Chronic Obstructive Pulmonary Disease Volume 2015:10(1) Pages 2207—2217 DOI 10.2147/COPD.S91694

Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study.
Braido F, Brusselle G, Guastalla D, Ingrassia E, Nicolini G, Price D, Roche N, Soriano JB, Worth H; LIAISON Study Group.
Respir Res. 2016 May 14;17(1):51. doi: 10.1186/s12931-016-0374-z.

Leukotriene Antagonists as First-Line or Add-on Asthma-Controller Therapy
David Price, F.R.C.G.P., Stanley D. Musgrave, M.D., Lee Shepstone, Ph.D., Elizabeth V. Hillyer, D.V.M., Erika J. Sims, Ph.D., Richard F.T. Gilbert, M.R.C.G.P., Elizabeth F. Juniper, M.C.S.P., M.Sc., Jon G. Ayres, M.D., Linda Kemp, B.Sc., Annie Blyth, M.A., Edward C.F. Wilson, M.Sc., Stephanie Wolfe, M.Sc., R.G.N., Daryl Freeman, M.R.C.G.P., H. Miranda Mugford, Ph.D., Jamie Murdoch, Ph.D., and Ian Harvey, F.R.C.P.
N Engl J Med 2011; 364:1695-1707May 5, 2011DOI: 10.1056/NEJMoa1010846

Are pharmacological randomised controlled clinical trials relevant to real-life asthma populations? A protocol for an UNLOCK study from the IPCRG
Karin Lisspers, Pedro Teixeira, Coert Blom, Janwillem Kocks, Björn Ställberg, David Price & Niels Chavannes
npj Primary Care Respiratory Medicine 26, Article number: 16016 (2016) doi:10.1038/npjpcrm.2016.16

The REporting of Studies Conducted Using Observational Routinely-Collected Health Data (RECORD) Statement: Methods for Arriving at Consensus and Developing Reporting Guidelines.
Nicholls SG, Quach P, von Elm E, Guttmann A, Moher D, Petersen I, Sørensen HT, Smeeth L, Langan SM, Benchimol EI.
PLoS One. 2015 May 12;10(5):e0125620. doi: 10.1371/journal.pone.0125620.

The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement.
Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, Sørensen HT, von Elm E, Langan SM; RECORD Working Committee.
PLoS Med. 2015 Oct 6;12(10):e1001885. doi: 10.1371/journal.pmed.1001885.

Are pharmacological randomised controlled clinical trials relevant to real-life asthma populations? A protocol for an UNLOCK study from the IPCRG
Karin Lisspers, Pedro Teixeira, Coert Blom, Janwillem Kocks, Björn Ställberg, David Price & Niels Chavannes
npj Primary Care Respiratory Medicine 26, Article number: 16016 (2016) doi:10.1038/npjpcrm.2016.16

Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry
Joan Sweeney, Chris C Patterson, Andrew Menzies-Gow, Rob M Niven, Adel H Mansur, Christine Bucknall, Rekha Chaudhuri, David Price, Chris E Brightling, Liam G Heaney on behalf of the British Thoracic Society Difficult Asthma Network
Thorax 2016 doi:10.1136/thoraxjnl-2015-207630

Asthma control with extrafine-particle hydrofluoroalkane–beclometasone vs. large-particle chlorofluorocarbon–beclometasone: a real-world observational study
Barnes, D. Price, G. Colice, A. Chisholm, P. Dorinsky, E. V. Hillyer, A. Burden, A. J. Lee, R. J. Martin, N. Roche, J. von Ziegenweidt and E. Israel
Clin Exp Allergy. 2011 Nov;41(11):1521-32. doi: 10.1111/j.1365-2222.2011.03820.x. Epub 2011 Jul 14.

Detection of airflow limitation using a handheld spirometer in a primary care setting. 
Ching SM, Pang YK, Price D, Cheong AT, Lee PY, Irmi I, Faezah H, Ruhaini I, Chia YC. 
Respirology. 2014 Jul;19(5):689-93. doi: 10.1111/resp.12291. Epub 2014 Apr 7.